Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response-Reference-Cited by-同舟云学术

Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response

Published:2021-11 Issue: Volume: Page:
ISSN:2095-8099
Container-title:Engineering
language:en
Short-container-title:Engineering

Author:

Zhao Lu,Liu Hao,Wang Yingchao,Wang Shufang,Xun Dejin,Wang Yi,Cheng Yiyu,Zhang Boli

Publisher

Elsevier BV

Subject

General Engineering,Energy Engineering and Power Technology,Materials Science (miscellaneous),General Chemical Engineering,Environmental Engineering,General Computer Science

Reference63 articles.

1. COVID-19: discovery, diagnostics and drug development;Asselah;J Hepatol,2021

2. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat Rev Microbiol,2021

3. Adaptive immunity to SARS-CoV-2 and COVID-19;Sette;Cell,2021

4. www.who.int [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Sep 22]. Available from: https://covid19.who.int.

5. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrathin Titanium Carbide-modified Separator for High-performance Lithium-Sulfur Batteries;Ceramics International;2024-08

2. Wen-Yi and Chinese medicine: Why we need to pay attention?;Science Bulletin;2024-06

3. Identification of Xuanfei Baidu granule constituents by liquid chromatography–quadruple‐time‐of‐flight–mass spectrometry and its anti‐inflammatory active constituents using a lipopolysaccharide‐induced RAW264.7 cell model;Biomedical Chromatography;2024-05-27

4. Exploring the Mechanisms of the Huangqin Qingfei Decoction in Pneumonia Treatment for Lipopolysaccharide-Induced Mouse Model: A Network Pharmacology Analysis and Experimental Validation;Natural Product Communications;2024-03

5. Polydatin ameliorates low-density lipoprotein cholesterol and lipid metabolism by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in triple-negative breast cancer with hyperlipidemia;American Journal of Cancer Research;2024